Luminex Q3 Revenues Double, Losses Narrow | GenomeWeb

NEW YORK, Oct. 22 (GenomeWeb News) – Luminex today reported increased net revenues for the third quarter, and significantly narrowed net losses.

The Austin, Texas company, which makes the xMap bead assay system for genomics and proteomics research and other applications, reported revenues of $7.2 million for the quarter, compared to $3.6 million for the third quarter of 2002. Net losses for the quarter came to $.9 million, compared to $5.8 million for the same period last year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.